These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7577315)

  • 1. [ACE inhibitors in the treatment of patients with acute myocardial infarct].
    Borghi C; Ambrosioni E
    Ann Ital Med Int; 1995; 10(3):175-87. PubMed ID: 7577315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
    Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
    Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE inhibitors: myocardial infarction and congestive heart failure.
    Cody RJ
    Am Fam Physician; 1995 Nov; 52(6):1801-6. PubMed ID: 7484690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing angiotensin-converting enzyme inhibitor trial results in patients with acute myocardial infarction.
    Cody RJ
    Arch Intern Med; 1994 Sep; 154(18):2029-36. PubMed ID: 8092908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trandolapril in the prevention of the sequelae of left ventricular systolic dysfunction after acute myocardial infarct].
    Buksa M
    Med Arh; 2000; 54(2):103-6. PubMed ID: 10934839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
    Saha SA; Molnar J; Arora RR
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trials with ACE-inhibitors in acute myocardial infarction].
    Dalla Volta S
    Cardiologia; 1994 Dec; 39(12 Suppl 1):149-55. PubMed ID: 7634258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ACE inhibitors in the treatment of patients after myocardial infarct].
    Widimský J
    Vnitr Lek; 1993 Jun; 39(6):527-35. PubMed ID: 8212605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What have the ACE-inhibitor trials in postmyocardial patients with left ventricular dysfunction taught us?
    Reynolds G; Hall AS; Ball SG
    Eur J Clin Pharmacol; 1996; 49 Suppl 1():S35-9. PubMed ID: 8834930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.
    Ueshima K; Fukami K; Hiramori K; Hosoda S; Kishida H; Kato K; Fujita T; Tsutani K; Sakuma A;
    Am Heart J; 2004 Aug; 148(2):e8. PubMed ID: 15309011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Converting enzyme inhibitors and coronary failure].
    Castaigne A; Saal JP; Albo C; Verschuren P; Pham I
    Rev Prat; 1992 Dec; 42(20):2568-73. PubMed ID: 1299942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB
    Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
    Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
    Mazzotta G; Vecchio C
    G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early or late ACE inhibition after myocardial infarction.
    Ball SG
    J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S18-21. PubMed ID: 7514236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of ACE inhibition in patients with acute myocardial infarction.
    Borghi C; Ambrosioni E
    Cardiovasc Drugs Ther; 1996 Nov; 10(5):519-25. PubMed ID: 8950065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.